IL259096A - Peptides and methods of treating endometriosis using the same - Google Patents

Peptides and methods of treating endometriosis using the same

Info

Publication number
IL259096A
IL259096A IL259096A IL25909618A IL259096A IL 259096 A IL259096 A IL 259096A IL 259096 A IL259096 A IL 259096A IL 25909618 A IL25909618 A IL 25909618A IL 259096 A IL259096 A IL 259096A
Authority
IL
Israel
Prior art keywords
peptides
methods
same
treating endometriosis
endometriosis
Prior art date
Application number
IL259096A
Other languages
Hebrew (he)
Original Assignee
Bioincept Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2015/058877 external-priority patent/WO2016073513A1/en
Application filed by Bioincept Llc filed Critical Bioincept Llc
Publication of IL259096A publication Critical patent/IL259096A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL259096A 2015-11-03 2018-05-02 Peptides and methods of treating endometriosis using the same IL259096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2015/058877 WO2016073513A1 (en) 2014-11-03 2015-11-03 Pif binding as a marker for immune dysregulation
US201662317628P 2016-04-03 2016-04-03
PCT/US2016/060319 WO2017079430A1 (en) 2015-11-03 2016-11-03 Peptides and methods of treating endometriosis using the same

Publications (1)

Publication Number Publication Date
IL259096A true IL259096A (en) 2018-06-28

Family

ID=58663080

Family Applications (1)

Application Number Title Priority Date Filing Date
IL259096A IL259096A (en) 2015-11-03 2018-05-02 Peptides and methods of treating endometriosis using the same

Country Status (5)

Country Link
EP (1) EP3377085A4 (en)
AU (1) AU2016349358B2 (en)
CA (1) CA3004055A1 (en)
IL (1) IL259096A (en)
WO (1) WO2017079430A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2996874A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Compositions and methods for the treatment of neurodamage
EP3341739A4 (en) 2015-08-28 2019-07-10 BioIncept LLC Mutant peptides and methods of treating subjects using the same
EP3655010A4 (en) * 2017-07-17 2021-06-09 Bioincept LLC Peptides and methods of transplantation and restorative organ function
US11884749B2 (en) * 2018-11-21 2024-01-30 Endomet Biosciences, Inc. Compositions and methods for treating endometriosis
CN113845582B (en) * 2021-10-15 2022-05-27 南京市妇幼保健院 Application of endogenous polypeptide in preparation of targeted drug for preventing or treating endometrial cancer
EP4248985A1 (en) * 2022-03-25 2023-09-27 Consejo Superior de Investigaciones Científicas (CSIC) Peptides for the treatment of retinitis pigmentosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
AU4233500A (en) * 1999-04-16 2000-11-02 Bioincept, Inc. Identification of a serum marker for endometriosis
US7723290B2 (en) * 2004-10-22 2010-05-25 Bioincept, Llc Compositions and methods for modulating the immune system
US7723289B2 (en) * 2003-10-22 2010-05-25 Bioincept, Llc PIF tetrapeptides
WO2014165282A1 (en) * 2013-03-12 2014-10-09 Institute of Arthritis Research, LLC Immunologically active polypeptide
US9783576B2 (en) * 2013-06-11 2017-10-10 Sanford-Burnham Medical Research Institute Compositions and methods for targeted endometriosis treatment
JP2017535794A (en) * 2014-11-03 2017-11-30 バイオインセプト、エルエルシー PIF binding as a marker for immune dysregulation

Also Published As

Publication number Publication date
WO2017079430A1 (en) 2017-05-11
EP3377085A4 (en) 2019-07-17
AU2016349358A1 (en) 2018-06-14
EP3377085A1 (en) 2018-09-26
CA3004055A1 (en) 2017-05-11
AU2016349358B2 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
HUS2400014I1 (en) Therapeutic antibodies and their uses
HK1249058A1 (en) Compounds and methods for the enhanced degradation of targeted proteins
ZA201802854B (en) Authentication methods and sysyems
IL256515A (en) Therapeutic peptides and methods of use thereof
LT3341027T (en) Transfection complexes and methods of using the same
HK1247091A1 (en) Therapeutic antibodies and uses thereof
IL259096A (en) Peptides and methods of treating endometriosis using the same
IL284236A (en) Modifications and uses of conotoxin peptides
HK1251979A1 (en) Peptide compositions and methods of use
IL284792A (en) Depdc1-derived peptide and vaccine containing same
ZA201901942B (en) Nnif and nnif-related peptides and related methods
HK1255695A1 (en) Composition and methods for the treatment of blepharoptosis
GB201517786D0 (en) Methods and materials
IL247448A0 (en) Peptides and methods of use
GB201421888D0 (en) Peptides derived from mysoin 19 and methods of use thereof
SG11201610918RA (en) Peptides and uses thereof
IL268844A (en) Peptides and methods of treating dystrophy-related disorders using the same
GB201617925D0 (en) Proteins and uses
TWI560711B (en) Fastening device and method of using the same
GB201512216D0 (en) Agents uses and methods
GB201501257D0 (en) Cover means and method of use thereof